Gastrointestinal stromal tumours
Gastrointestinal stromal tumours (GIST) have an incidence of~ 1.2 per 105 individuals per
year in most countries. Around 80% of GIST have varying molecular changes, predominantly …
year in most countries. Around 80% of GIST have varying molecular changes, predominantly …
Soft‐tissue sarcoma in adults: an update on the current state of histiotype‐specific management in an era of personalized medicine
AC Gamboa, A Gronchi… - CA: a cancer journal for …, 2020 - Wiley Online Library
Soft‐tissue sarcomas (STS) are rare tumors that account for 1% of all adult malignancies,
with over 100 different histologic subtypes occurring predominately in the trunk, extremity …
with over 100 different histologic subtypes occurring predominately in the trunk, extremity …
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma …
S Bonvalot, PL Rutkowski, J Thariat, S Carrère… - The Lancet …, 2019 - thelancet.com
Background Pathological complete response to preoperative treatment in adults with soft-
tissue sarcoma can be achieved in only a few patients receiving radiotherapy. This phase 2 …
tissue sarcoma can be achieved in only a few patients receiving radiotherapy. This phase 2 …
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
G Shen, F Zheng, D Ren, F Du, Q Dong, Z Wang… - Journal of hematology & …, 2018 - Springer
Anlotinib is a new, orally administered tyrosine kinase inhibitor that targets vascular
endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet …
endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet …
Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group
CJ Swallow, DC Strauss, S Bonvalot… - Annals of surgical …, 2021 - Springer
Background Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare
tumors of mesenchymal origin that include several well-defined histologic subtypes. In 2015 …
tumors of mesenchymal origin that include several well-defined histologic subtypes. In 2015 …
Ultra‐rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
S Stacchiotti, AM Frezza, JY Blay, EH Baldini… - Cancer, 2021 - Wiley Online Library
Background Among sarcomas, which are rare cancers, many types are exceedingly rare;
however, a definition of ultra‐rare cancers has not been established. The problem of ultra …
however, a definition of ultra‐rare cancers has not been established. The problem of ultra …
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) …
A Gronchi, E Palmerini, V Quagliuolo… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To determine whether the administration of histology-tailored neoadjuvant
chemotherapy (HT) was superior to the administration of standard anthracycline plus …
chemotherapy (HT) was superior to the administration of standard anthracycline plus …
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network
G De Pinieux, M Karanian, F Le Loarer, S Le Guellec… - PLoS …, 2021 - journals.plos.org
Background Since 2010, nationwide networks of reference centers for sarcomas
(RREPS/NETSARC/RESOS) collected and prospectively reviewed all cases of sarcomas …
(RREPS/NETSARC/RESOS) collected and prospectively reviewed all cases of sarcomas …
[HTML][HTML] Surgery in reference centers improves survival of sarcoma patients: a nationwide study
JY Blay, C Honore, E Stoeckle, P Meeus, M Jafari… - Annals of …, 2019 - Elsevier
Background NETSARC (netsarc. org) is a network of 26 sarcoma reference centers with
specialized multidisciplinary tumor boards (MDTB) aiming to improve the outcome of …
specialized multidisciplinary tumor boards (MDTB) aiming to improve the outcome of …
[HTML][HTML] Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
S Stacchiotti, AB Miah, AM Frezza, C Messiou… - ESMO open, 2021 - Elsevier
Highlights•This consensus paper provides key recommendations on the management of
epithelioid hemangioendothelioma (EHE).•Recommendations followed a consensus …
epithelioid hemangioendothelioma (EHE).•Recommendations followed a consensus …